FY 2021 vs. FY 2020 Restated Net Sales New Segment Presentation Less: Impact Less: Impact of Foreign of Recent FY FY As Reported Currency Operational Acquisitions / Organic (in millions) 2021 2020 Basis Fluctuations Basis Divestitures Basis ENDOSCOPY $ 2,141 $ 1,780 20.3 % 1.3 % 18.9 % — % 18.9 % UROLOGY 1,583 1,286 23.1 % 1.0 % 22.1 % 2.8 % 19.2 % NEUROMODULATION 909 761 19.5 % 0.9 % 18.6 % — % 18.6 % MEDSURG 4,633 3,827 21.0 % 1.1 % 19.9 % 1.0 % 18.9 % ICTx 2,209 1,975 11.8 % 1.6 % 10.3 % — % 10.3 % WATCHMAN 829 324 156.0 % 1.1 % 154.9 % — % 154.9 % CARDIAC RHYTHM MANAGEMENT 2,019 1,704 18.5 % 1.4 % 17.1 % 9.5 % 7.7 % ELECTROPHYSIOLOGY 365 287 27.4 % 1.6 % 25.8 % 2.3 % 23.5 % CARDIOLOGY 5,422 4,290 26.4 % 1.5 % 25.0 % 3.9 % 21.0 % PERIPHERAL INTERVENTIONS 1,820 1,577 15.4 % 1.2 % 14.2 % — % 14.2 % CARDIOVASCULAR 7,242 5,866 23.4 % 1.4 % 22.1 % 2.9 % 19.2 % 11,875 9,694 22.5 % 1.3 % 21.2 % 2.1 % 19.1 % † OTHER 13 219 (93.9) % 0.1 % (94.0) % (49.6) % (44.4) % WORLDWIDE NET SALES $ 11,888 $ 9,913 19.9 % 1.3 % 18.7 % (0.3) % 18.9 % 31 Q4 2022 Financial & Operational Highlights | February 1, 2023